Specialization & Approach
Dr. Wright's research is dedicated to examining and analyzing the complex chemical structures of mitragynine and its derivatives, particularly 7-hydroxymitragynine (7-HM). His expertise lies in designing and implementing specialized synthetic protocols to develop novel compounds with enhanced pharmacological properties. He leverages advanced computational tools to predict and explain molecular interactions, enabling a more precise understanding of these alkaloids' therapeutic potential.
Dr. Wright's research is grounded in rigorous scientific methodology, combining experimental synthesis and pharmacological testing with advanced computational modeling. His approach ensures that contributions to the field are based on robust data and sound principles, enhancing the reliability of findings.
Fundamental Skills & Expertise
Notable Experiences
- Developed a novel synthetic route for the production of highly pure 7-HM, increasing yield by 30% compared to traditional methods.
- Conducted comprehensive in vitro and in vivo studies demonstrating the anti-inflammatory and analgesic efficacy of 7-HM derivatives.
- Published 15 peer-reviewed articles in top-tier journals, contributing to the global body of knowledge on mitragynine-based pharmaceuticals.
- Spearheaded a collaborative research initiative resulting in the design of a new class of non-opioid pain relievers with reduced side effects.
Qualifications & Certifications
- PhD in Pharmaceutics, University of Cambridge
- Postdoctoral Fellowship, Massachusetts Institute of Technology (MIT)
- Certified Specialist in Computational Biology
- Member, American Chemical Society (ACS)
Honors & Trust Marks
- Served as principal investigator on multiple NSF-funded research projects.
- Regularly reviews manuscripts for high-impact journals, ensuring academic rigor and quality.
- Invited speaker at international conferences, sharing expertise with global scientific communities.
